• Contact us
  • E-Submission

Ewha Med J : The Ewha Medical Journal

OPEN ACCESS
mobile search button mobile menu button
Search
Advanced Search
ABOUT
BROWSE ARTICLES
JOURNAL POLICIES
FOR CONTRIBUTORS

Articles

Page Path

Review Article
Special Issues for Breast Cancer

Current Status of Breast Cancer in Korea

Nam-Sun Paik
The Ewha Medical Journal 2014;37(2):69-74. Published online: September 30, 2014

Ewha Womans University Cancer Center for Women, Seoul, Korea.

Corresponding author: Nam-Sun Paik. Ewha Womans University Cancer Center for Women, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul 158-710, Korea. Tel: 82-2-2650-2800, Fax: 82-2-2650-2802, namsun.paik@gmail.com
• Received: August 5, 2013   • Accepted: September 3, 2013

Copyright © 2014. Ewha Womans University School of Medicine

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 52 Views
  • 0 Download
  • 5 Crossref
prev next

Full Article

Download PDF Download PDF
  • Malignant neoplasm is the most common cause of death in Korea since 1988. In terms of incidence, still gastric cancer is the most common cancer in male, but breast cancer became the second most common female cancer followed by thyroid cancer. The reasons why incidence of breast cancer is increasing, (1) Westernized food patterns; high fat and high calorie diet, (2) late marriage with lower birth rate, (3) shorter period of breast feeding, (4) longer exposure to estrogen; early menarche with late menopause, hormone replacement therapy, (5) low physical activity with high body mass index, (6) environmental stress, and etc. Still incidence of breast cancer in Korea is relatively low comparing to those of American and European populations, but it is very rapidly increasing with annual increase rate of about 6%. So Korean breast cancer specialists should try to study breast cancer in terms of basic and also clinical aspect and also educate laymen for etiology, symptoms and signs, early detection method including breast self-examination and prevention.
  • Keywords: Breast neoplasms; Korea; Etiology; Treatment; Prevention
  • 1. Korean Breast Cancer SocietyKorean breast cancer data of 1997. J Korean Cancer Assoc 1999;31:1202-1209.
  • 2. Central Cancer Registry Center in Korea.Cancer facts and figures 2013; Seoul: Ministry of Health and Welfare; 2013.
  • 3. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000;50:7-33.
  • 4. Kim Z, Min SY, Yoon CS, Lee HJ, Lee JS, Youn HJ, et al. The basic facts of korean breast cancer in 2011: results of a nationwide survey and breast cancer registry database. J Breast Cancer 2014;17:99-106.
  • 5. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29.
  • 6. Tominaga S, Oshima A. Cancer mortality and morbidity statistics: Japan and the world; Tokyo: S Karger Pub; 1999.
  • 7. Chu KC, Tarone RE, Kessler LG, Ries LA, Hankey BF, Miller BA, et al. Recent trends in US breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 1996;88:1571-1579.
  • 8. Mettlin C. Global breast cancer mortality statistics. CA Cancer J Clin 1999;49:138-144.
  • 9. Study Group for Korean Hereditary Breast Cancer.Hereditary breast cancer; Seoul: Koonja Medical Book Publisher; 2012.
  • 10. Chlebowski RT, Collyar DE, Somerfield MR, Pfister DG. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene. J Clin Oncol 1999;17:1939-1955.
  • 11. Kim HH. Breast cancer screening and prevention. The Korean Breast Cancer Society.The Breast; 2nd ed. Seoul: Ilchokak; 2012 254280.
  • 12. Paik NS. Chemoprevention for breast cancer, cancer chemoprevention; Seoul: Korea Medical Book Publisher; 2000.
  • 13. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371-1388.
  • 14. Jordan VC. Antitumour activity of the antioestrogen ICI 46,474(tamoxifen) in the dimethyl benzathracene (DMBA)-induced rat mammary carcinoma model. J Steroid Biochem 1974;5:354.
  • 15. Jordan VC. Effect of tamoxifen (ICI 46,474) on inititation and growth of DMBA-induced rat mammary carcinoma. Eur J Cancer 1976;12:419-425.
  • 16. Fisher B, Dignam J, Wolmark N, DeCillis A, Emir B, Wickerham DL, et al. Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. J Natl Cancer Inst 1997;89:1673-1682.
  • 17. Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 2006;24:3726-3734.
  • 18. Veronesi U, Saccozzi R, Del Vecchio M, Banfi A, Clemente C, De Lena M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 1981;305:6-11.
  • 19. Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot JH, Jager JJ, et al. EORTC Radiotherapy and Breast Cancer Cooperative GroupsThe influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. Radiother Oncol 2000;55:219-232.
  • 20. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-339.
  • 21. Ollila DW, Brennan MB, Giuliano AE. Therapeutic effect of sentinel lymphadenectomy in T1 breast cancer. Arch Surg 1998;133:647-651.
  • 22. Keleher AJ, Theriault RL, Gwyn KM, Hunt KK, Stelling CB, Singletary SE, et al. Multidisciplinary management of breast cancer concurrent with pregnancy. J Am Coll Surg 2002;194:54-64.
  • 23. Peterson NB, Huang Y, Newcomb PA, et al. Childbearing recency and modifiers of premenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 2008;17:3284-3287.
  • 24. Nechuta S, Paneth N, Velie EM. Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature. Cancer Causes Control 2010;21:967-989.
  • 25. Rochefort H, Garcia M, Glondu M, Laurent V, Liaudet E, Rey JM, et al. Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview. Clin Chim Acta 2000;291:157-170.
  • 26. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
  • 27. Jordan VC, Allen KE, Dix CJ. Pharmacology of tamoxifen in laboratory animals. Cancer Treat Rep 1980;64:745-759.
  • 28. Assikis VJ, Jordan VC. Gynecologic effects of tamoxifen and the association with endometrial carcinoma. Int J Gynaecol Obstet 1995;49:241-257.
  • 29. Costantino JP, Kuller LH, Ives DG, Fisher B, Dignam J. Coronary heart disease mortality and adjuvant tamoxifen therapy. J Natl Cancer Inst 1997;89:776-782.
  • 30. McDonald CC, Alexander FE, Whyte BW, Forrest AP, Stewart HJ. The Scottish Cancer Trials Breast GroupCardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial. BMJ 1995;311:977-980.
  • 31. Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 1994;86:527-537.
  • 32. Veronesi U, Maisonneuve P, Costa A, Sacchini V, Maltoni C, Robertson C, et al. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study. Lancet 1998;352:93-97.
Fig. 1
Number of newly-diagnosed breast cancer patients according to the Korean Breast Cancer Society survey [2].
emj-37-69-g001.jpg

Figure & Data

References

    Citations

    Citations to this article as recorded by  
    • Path Analysis of Attitude Toward Health Checkup and Breast Cancer on the Application of Physical Therapy after Breast Cancer Surgery
      Mi-Joung Lee, Hyo-Lyun Ro
      Journal of The Korean Society of Physical Medicine.2021; 16(4): 45.     CrossRef
    • A comparative study of the clinical characteristics of breast cancer patients less than 35 years old and older patients
      Tae Sik Hwang, Ah Rem Jeong, Joung Won Na, Yun Yeong Kim, Joon-Hyop Lee, Yoo Seung Chung, Sang Tae Choi, Jin Mo Kang, Heung Kyu Park, Yong Soon Chun
      Korean Journal of Clinical Oncology.2018; 14(1): 1.     CrossRef
    • Effect of Antioxidant Activities and Apoptosis Induction of Salvia plebeia R. Br. in Human Breast Cancer MCF-7 Cells
      Hyun A Kim, Joomin Lee
      The Korean Journal of Community Living Science.2018; 29(2): 197.     CrossRef
    • Dietary Factors and Female Breast Cancer Risk: A Prospective Cohort Study
      Ji Kim, Jeonghee Lee, So-Youn Jung, Jeongseon Kim
      Nutrients.2017; 9(12): 1331.     CrossRef
    • A Case of Esophageal Stricture Due to Metastatic Breast Cancer Diagnosed by Using Endoscopic Ultrasound Guided Fine Needle Biopsy
      Shang Hoon Han, Min A Yang, Jae Un Lee, Moon Sik Park, Young Jae Lee, Ji Woong Kim, Myoung Jin Ju, Jin Woong Cho
      The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2015; 15(2): 136.     CrossRef

    Download Citation

    Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

    Format:

    Include:

    Current Status of Breast Cancer in Korea
    Ewha Med J. 2014;37(2):69-74.   Published online September 30, 2014
    DOI: https://doi.org/10.12771/emj.2014.37.2.69
    Download Citation
    Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.
    Format:
    • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
    • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
    Include:
    • Citation for the content below
    Current Status of Breast Cancer in Korea
    Ewha Med J. 2014;37(2):69-74.   Published online September 30, 2014
    DOI: https://doi.org/10.12771/emj.2014.37.2.69
    Close

    Figure

    • 0
    Current Status of Breast Cancer in Korea
    Image
    Fig. 1 Number of newly-diagnosed breast cancer patients according to the Korean Breast Cancer Society survey [2].

    Fig. 1

    Current Status of Breast Cancer in Korea
    Ewha Med J : The Ewha Medical Journal

    ABOUT

    BROWSE ARTICLES 

    JOURNAL POLICIES

    FOR CONTRIBUTORS 

    © Ewha Womans University College of Medicine.
    TOP